Retail Trade
MatsukiyoCocokara & Co.
In the news
- No more backroom deals, Japanese M&A hunts for best offers Aug 17, 2019
- Japan drugstore chain Cocokara to pursue Matsumotokiyoshi merger Aug 14, 2019
- Japan retailers feel chill with big-spending Chinese gone Aug 10, 2019
- Drugstore Matsumotokiyoshi heads to Hong Kong and Vietnam Jul 17, 2019
- Once-mum Japan shareholders crank up pressure on management Jul 6, 2019 See more articles on MatsukiyoCocokara & Co.
Business Summary
MatsukiyoCocokara & Co. engages in the management and supervision of its group companies that are in drugstore and pharmacy operations. It operates through the following segments: Retail Business, Wholesale Business, and Management Support. The Retail Business segment deals with the retail sales of pharmaceutical and related products. The Wholesale Business segment operates as a wholesale distributor of medicines and miscellaneous daily goods, and offers franchising services. The Management Support segment manages the Group and indirect operations. The company was founded on October 1, 2007 and is headquartered in Matsudo, Japan.
Financial Highlights
| Mar 2021 | JPY | USD |
| Revenue | 556,907M | 5,250.99M |
| Gross Profit | 173,518M | 1,636.07M |
| Operating income | 31,522M | 297.21M |
| Income before tax | 32,617M | 307.54M |
| Net income | 21,568M | 203.36M |
| EBITDA | 40,100M | 378.09M |
| Diluted EPS | 210.03 | 1.98 |
| Dividends Per Share | 70 | 0.66 |
| Total Assets | 368,924M | 3,338.67M |
| Total liabilities | 122,458M | 1,108.21M |
| Total equity | 246,461M | 2,230.41M |
| Operating cash flow | 25,875M | 243.97M |
| Currency in JPY | Currency in USD |
Historical Data
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
| Revenue | 535,133M | 558,879M | 575,991M | 590,593M | 556,907M |
| Gross Profit | 150,340M | 161,502M | 171,249M | 181,036M | 173,518M |
| Operating income | 28,431M | 33,567M | 36,029M | 37,554M | 31,522M |
| Income before tax | 28,815M | 34,418M | 37,369M | 39,078M | 32,617M |
| Net income | 20,119M | 22,755M | 25,035M | 26,176M | 21,568M |
| EBITDA | 36,376M | 41,271M | 44,262M | 45,957M | 40,100M |
| Diluted EPS | 188.97 | 214.92 | 239.32 | 254.93 | 210.03 |
| Dividends Per Share | 47.50 | 55 | 65 | 70 | 70 |
| Total Assets | 285,733M | 314,178M | 318,324M | 351,809M | 368,924M |
| Total liabilities | 101,670M | 109,303M | 109,050M | 122,499M | 122,458M |
| Total equity | 184,060M | 204,871M | 209,269M | 229,304M | 246,461M |
| Operating cash flow | 23,719M | 27,938M | 21,897M | 24,764M | 25,875M |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | |
| Revenue | 4,941.77M | 5,042.55M | 5,194.03M | 5,431.95M | 5,250.99M |
| Gross Profit | 1,388.34M | 1,457.17M | 1,544.24M | 1,665.06M | 1,636.07M |
| Operating income | 262.55M | 302.86M | 324.89M | 345.40M | 297.21M |
| Income before tax | 266.09M | 310.54M | 336.97M | 359.41M | 307.54M |
| Net income | 185.79M | 205.30M | 225.75M | 240.75M | 203.36M |
| EBITDA | 335.92M | 372.37M | 399.13M | 422.68M | 378.09M |
| Diluted EPS | 1.74 | 1.93 | 2.15 | 2.34 | 1.98 |
| Dividends Per Share | 0.43 | 0.49 | 0.58 | 0.64 | 0.66 |
| Total Assets | 2,564.23M | 2,954.18M | 2,875.94M | 3,258.84M | 3,338.67M |
| Total liabilities | 912.41M | 1,027.76M | 985.22M | 1,134.72M | 1,108.21M |
| Total equity | 1,651.79M | 1,926.38M | 1,890.67M | 2,124.07M | 2,230.41M |
| Operating cash flow | 219.03M | 252.07M | 197.45M | 227.76M | 243.97M |
Valuation Measures
| Mar 2021 | |
| PER | 23.46 |
| ROA | 5.98% |
| ROE | 9.06% |
| Operating margin | 5.66% |
| Profit margin | 3.87% |
Key executives
- President & Representative Director: Kiyoo Matsumoto
- Manager-Finance & Accounting: Hiroshi Nishida
- Senior Manager-Information System: Hidesato Hiramatsu
- Representative Director & Vice President: Atsushi Tsukamoto
- Executive Officer & Head-Kyushu Sales: Takao Watanabe
Shareholders
- MatsukiyoCocokara & Co. (5.0%)
- MATSUMOTO NAMIO (5.0%)
- The Chiba Bank, Ltd. (3.5%)
- Nomura Asset Management Co., Ltd. (3.2%)
- Columbia Management Investment Advisers LLC (2.2%)
- Eisai Co., Ltd. (1.9%)
- The Vanguard Group, Inc. (1.8%)
- T. Rowe Price International Ltd. (1.7%)
- MATSUMOTO TAKASHI /MATSUMOTOKIYOSHI/ (1.7%)
- MATSUMOTO KIYOO (1.7%)
Contact Details
- Website:http://www.matsumotokiyoshi-hd.co.jp
- Phone: +81.47.344.5110
Related Companies
- Matsumotokiyoshi Insurance Service Co., Ltd.
- Matsumotokiyoshi Wholesale Co., Ltd.
- Matsumotokiyoshi Pharmacies Co., Ltd.
- Matsumotokiyoshi Kyushu Sales Co., Ltd.
- Matsumotokiyoshi Hd Restricted Stock Compensation Plan
- Matsumotokiyoshi Holdings Employee Incentive Plan
- Matsumotokiyoshi Holdings Board Incentive Plan
- Daruma Drug Co., Ltd.
- Matsumotokiyoshi Kou-Shin-Etsu Japan Co., Ltd.
- Yukari Kokoku KK
- MK Higashinihon Hambai KK
- Tobu Drug KK
- MK Planning KK
- Moris Retail KK
- Koyo Yakuhin Co., Ltd.
- Sugiura Co., Ltd.
- Itayama Medico Co. Ltd.
- Nakajima Family Yakkyoku KK
- Shimeno Yakkyoku KK
- Matsumotokiyoshi Asset Management Co., Ltd.
- cocokara fine Inc.
- Love Drugs Co., Ltd.
- Matsumotokiyoshi Co., Ltd.
- Midoriyakuhin Co., Ltd.
Competitors
- GS Retail Co., Ltd.
Copyright © 2021 FactSet Research Systems Inc. All rights reserved.
Last Updated on 3 Dec, 2021Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.